FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949901067> ?p ?o ?g. }

• W2949901067 endingPage "720" @default.
• W2949901067 startingPage "712" @default.
• W2949901067 abstract "Background: Immune checkpoint inhibitors (ICIs) may cause immune-related adverse events (irAEs). Methods to obtain real-time multidisciplinary input for irAEs that require subspecialist care are unknown. This study aimed to determine whether a virtual multidisciplinary immune-related toxicity (IR-tox) team of oncology and medicine subspecialists would be feasible to implement, be used by oncology providers, and identify patients for whom multidisciplinary input is sought. Patients and Methods: Patients treated with ICIs and referred to the IR-tox team in August 2017 through March 2018 were identified. Feasibility was defined as receipt of electronic referrals and provision of recommendations within 24 hours of referral. Use was defined as the proportion of referring providers who used the team’s recommendations, which was determined through a postpilot survey. Demographics and tumor, treatment, and referral data were collected. Patient features and irAE associations were analyzed. Results: The IR-tox team was found to be feasible and used: 117 referrals from 102 patients were received in 8 months, all providers received recommendations within 24 hours, 100% of surveyed providers used the recommendations, and 74% changed patient management based on IR-tox team recommendations. Referrals were for suspected irAEs (n=106; 91%) and suitability to treat with ICIs (n=11; 10%). In referred patients, median age was 64 years, 54% were men, 13% had prior autoimmunity, and 46% received ICI combinations versus monotherapy (54%). The most commonly referred toxicities were pneumonitis (23%), arthritis (16%), and dermatitis (15%); 15% of patients had multisystem toxicities. Multiple referrals were more common in those treated with combination ICIs (odds ratio [OR], 6.0; P =.035) or with multisystem toxicities (OR, 8.1; P =.005). The IR-tox team provided a new multidisciplinary forum to assist providers in diagnosing and managing complex irAEs. This model identifies educational and service needs, and patients with irAEs for whom multidisciplinary care is most sought. Conclusions: A virtual multidisciplinary toxicity team for irAEs was a feasible and used service, and facilitated toxicity identification and management." @default.
• W2949901067 created "2019-06-27" @default.
• W2949901067 creator A5000610272 @default.
• W2949901067 creator A5005254334 @default.
• W2949901067 creator A5014494747 @default.
• W2949901067 creator A5018401879 @default.
• W2949901067 creator A5036748733 @default.
• W2949901067 creator A5044290840 @default.
• W2949901067 creator A5044692746 @default.
• W2949901067 creator A5049554147 @default.
• W2949901067 creator A5053818563 @default.
• W2949901067 creator A5059543131 @default.
• W2949901067 creator A5061423055 @default.
• W2949901067 creator A5062196360 @default.
• W2949901067 creator A5062709913 @default.
• W2949901067 creator A5063641495 @default.
• W2949901067 creator A5065333727 @default.
• W2949901067 creator A5066707073 @default.
• W2949901067 creator A5070925575 @default.
• W2949901067 creator A5074434599 @default.
• W2949901067 creator A5077671918 @default.
• W2949901067 creator A5080705478 @default.
• W2949901067 date "2019-06-01" @default.
• W2949901067 modified "2023-10-11" @default.
• W2949901067 title "A Multidisciplinary Toxicity Team for Cancer Immunotherapy–Related Adverse Events" @default.
• W2949901067 cites W1605315445 @default.
• W2949901067 cites W1605630196 @default.
• W2949901067 cites W1974455441 @default.
• W2949901067 cites W2004374768 @default.
• W2949901067 cites W2026615468 @default.
• W2949901067 cites W2157287584 @default.
• W2949901067 cites W2418354692 @default.
• W2949901067 cites W2484274124 @default.
• W2949901067 cites W2753432434 @default.
• W2949901067 cites W2754562068 @default.
• W2949901067 cites W2757648331 @default.
• W2949901067 cites W2770012581 @default.
• W2949901067 cites W2783137027 @default.
• W2949901067 cites W2786403629 @default.
• W2949901067 cites W2792937256 @default.
• W2949901067 cites W2797675588 @default.
• W2949901067 doi "https://doi.org/10.6004/jnccn.2018.7268" @default.
• W2949901067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31200355" @default.
• W2949901067 hasPublicationYear "2019" @default.
• W2949901067 type Work @default.
• W2949901067 sameAs 2949901067 @default.
• W2949901067 citedByCount "64" @default.
• W2949901067 countsByYear W29499010672019 @default.
• W2949901067 countsByYear W29499010672020 @default.
• W2949901067 countsByYear W29499010672021 @default.
• W2949901067 countsByYear W29499010672022 @default.
• W2949901067 countsByYear W29499010672023 @default.
• W2949901067 crossrefType "journal-article" @default.
• W2949901067 hasAuthorship W2949901067A5000610272 @default.
• W2949901067 hasAuthorship W2949901067A5005254334 @default.
• W2949901067 hasAuthorship W2949901067A5014494747 @default.
• W2949901067 hasAuthorship W2949901067A5018401879 @default.
• W2949901067 hasAuthorship W2949901067A5036748733 @default.
• W2949901067 hasAuthorship W2949901067A5044290840 @default.
• W2949901067 hasAuthorship W2949901067A5044692746 @default.
• W2949901067 hasAuthorship W2949901067A5049554147 @default.
• W2949901067 hasAuthorship W2949901067A5053818563 @default.
• W2949901067 hasAuthorship W2949901067A5059543131 @default.
• W2949901067 hasAuthorship W2949901067A5061423055 @default.
• W2949901067 hasAuthorship W2949901067A5062196360 @default.
• W2949901067 hasAuthorship W2949901067A5062709913 @default.
• W2949901067 hasAuthorship W2949901067A5063641495 @default.
• W2949901067 hasAuthorship W2949901067A5065333727 @default.
• W2949901067 hasAuthorship W2949901067A5066707073 @default.
• W2949901067 hasAuthorship W2949901067A5070925575 @default.
• W2949901067 hasAuthorship W2949901067A5074434599 @default.
• W2949901067 hasAuthorship W2949901067A5077671918 @default.
• W2949901067 hasAuthorship W2949901067A5080705478 @default.
• W2949901067 hasBestOaLocation W29499010671 @default.
• W2949901067 hasConcept C121608353 @default.
• W2949901067 hasConcept C126322002 @default.
• W2949901067 hasConcept C144024400 @default.
• W2949901067 hasConcept C149923435 @default.
• W2949901067 hasConcept C159110408 @default.
• W2949901067 hasConcept C194828623 @default.
• W2949901067 hasConcept C197934379 @default.
• W2949901067 hasConcept C22467394 @default.
• W2949901067 hasConcept C2776135927 @default.
• W2949901067 hasConcept C2777701055 @default.
• W2949901067 hasConcept C2777714996 @default.
• W2949901067 hasConcept C2779524853 @default.
• W2949901067 hasConcept C2780057760 @default.
• W2949901067 hasConcept C2780084366 @default.
• W2949901067 hasConcept C3020501284 @default.
• W2949901067 hasConcept C36289849 @default.
• W2949901067 hasConcept C512399662 @default.
• W2949901067 hasConcept C71924100 @default.
• W2949901067 hasConceptScore W2949901067C121608353 @default.
• W2949901067 hasConceptScore W2949901067C126322002 @default.
• W2949901067 hasConceptScore W2949901067C144024400 @default.
• W2949901067 hasConceptScore W2949901067C149923435 @default.
• W2949901067 hasConceptScore W2949901067C159110408 @default.
• W2949901067 hasConceptScore W2949901067C194828623 @default.

• next